Urine Fentanyl Screen
A urine screen for fentanyl, a very strong opioid, and norfentanyl, its main breakdown product. A positive result is presumptive until confirmed.
AI-verified against cited sources. Awaiting expert reviewAlso called FENT, NFENT, FENLOINC 59673-4
What it is
Fentanyl is a synthetic opioid that is far stronger than morphine. It is used as a prescription medicine for severe pain, for example in patches or in hospital care. It is also made illegally and sometimes mixed into other drugs. The body breaks fentanyl down into norfentanyl, which many screens look for. The test is an immunoassay with a set cutoff, and the cutoff differs between assays.
Why it matters
A standard opiate screen does not detect fentanyl, so it needs its own test. Because fentanyl can be mixed into other drugs, a positive result is not always something a person knew they took. Clinicians use this test to understand exposure and to make pain and opioid use disorder care safer. A positive is best read with your medicine list and, when the answer matters, a confirmation test.
If it’s high
A positive result means the screen found fentanyl or norfentanyl at or above the assay's cutoff. It does not show how much was taken or when, and it cannot tell prescribed use from other use. Low-level positives are the least certain, and different assays often disagree at low levels.
Common causes
- Fentanyl prescribed for pain, such as a patch, or given during surgery or hospital care
- Fentanyl taken outside of medical care, including exposure to fentanyl mixed into other drugs without knowing
- Norfentanyl still in the urine from earlier use, because it clears more slowly than fentanyl
- A false positive from a look-alike substance; high amounts of loperamide have been reported to do this on some assays
- A lab or sample mix-up (rare)
What can help
- Tell your clinician about every medicine you take or were given, including patches and any recent surgery or hospital care
- Ask whether a confirmation test (LC-MS/MS) was done or can be added, especially for a low-level positive
- Ask which assay and cutoff the lab used
- Ask your clinician whether naloxone and overdose-prevention information make sense for you and the people you live with
What can affect your result
- The assay and its cutoff; published fentanyl screens use cutoffs of about 1 to 5 ng/mL
- How well the assay detects norfentanyl
- Time since the last exposure: fentanyl clears within days, while norfentanyl can last longer
- Long-term use, liver problems, obesity and some genetic differences, which can slow how fast the body clears fentanyl
- How dilute the urine is
- Whether the assay reacts with fentanyl-related drugs
- Screens differ in how well they detect norfentanyl, fentanyl's main breakdown product. Published claims range from about 7% to 100% cross-reactivity, so two assays can disagree on low-level samples.
- High amounts of loperamide (an anti-diarrheal) and its breakdown product have caused false-positive fentanyl screens on some assays.
- Fentanyl-related drugs (analogs) react with some screens and not others. One FDA-cleared fentanyl strip reacts to acetyl fentanyl but not to carfentanil.
- Very dilute urine can push levels below the cutoff.
- A standard opiate screen does not detect fentanyl, so it needs its own test.
Any time of day. Collection is sometimes supervised in treatment, workplace and legal settings. Fentanyl itself usually clears within about 4 days, but norfentanyl lasts longer. In unusual cases low levels have been found for months after the last reported use.
When to talk to a clinician
A screen result on its own is not an emergency. If you or someone near you has slow or shallow breathing, extreme sleepiness, blue or gray lips, or can't be woken, call 911 or your local emergency number right away.
Questions you could ask
- Should this test be part of my regular drug screen panel, given my situation?
- Was my sample sent for a confirmation test?
- Could a medicine I was given, such as in a hospital or for pain, explain this result?
- Which assay and cutoff did the lab use?
Questions people ask
Why was my fentanyl screen positive when I only took a prescribed medicine?
Fentanyl is also a prescription medicine, so a patch or hospital care can cause a positive result. A look-alike substance can also cause a false positive. Share your full medicine list with the person who ordered the test, and ask whether a confirmation test is possible.
Why do two labs disagree on a low-level result?
Assays differ in their cutoffs and in how well they detect norfentanyl. In one study, only about 3 in 10 low-level positives agreed across three assays. A confirmation test is more exact.
Does a standard opiate test include fentanyl?
No. Standard opiate screens look for morphine-type drugs and miss fentanyl, which is why a separate fentanyl test exists.
Show the science and sources
For clinicians and researchers
Most fentanyl screens are enzyme immunoassays calibrated to fentanyl or to norfentanyl and read against a cutoff; rapid lateral-flow tests also exist. The HHS federal workplace panel uses 1 ng/mL for the initial and confirmatory fentanyl tests (confirmatory results cover fentanyl and norfentanyl at 1 ng/mL each) and requires an assay with at least 5% cross-reactivity to norfentanyl. Published assays differ: the ARK II and Thermo DRI II claim about 7% cross-reactivity with norfentanyl, the Lin-Zhi II assay claims 100% with a 5 ng/mL norfentanyl cutoff, and an Immunalysis assay used a 4 ng/mL fentanyl calibrator. In 2025 an FDA 510(k) for the Lin-Zhi LZI Fentanyl III changed the analyte from norfentanyl to fentanyl and the cutoff from 5 to 1 ng/mL. In a 2024 study of 92 low-positive Lin-Zhi II samples, 51% had only norfentanyl (under 2 ng/mL) on LC-MS/MS and only 29% were concordant across LC-MS/MS and the three immunoassays, so low-level screens often disagree. Fentanyl not stored in fat clears within about 4 days, while norfentanyl is longer-lasting; a case series found low norfentanyl 126 to 294 days after the last reported use in three women in a buprenorphine treatment program during pregnancy and after birth. Loperamide and its metabolite N-desmethyl loperamide gave positive results on the Thermo DRI and Immunalysis assays at concentrations above about 6 to 36 mg/L. Analog cross-reactivity varies: one cleared norfentanyl strip reacts to acetyl fentanyl (100%) but is negative for carfentanil at 500 ng/mL. The CDC 2022 guideline notes that testing for fentanyl is not available in widely used toxicology assays.
LOINC 59673-4 (primary), 58379-9, 95797-7, 113379-2, 114025-0, 40839-3, 66129-8, 11235-9. Specimen: urine.
Sources
- Mandatory Guidelines for Federal Workplace Drug Testing Programs: Authorized Testing Panels (91 FR 12308), HHS / SAMHSA, via the Federal Register (2026)
- CDC Clinical Practice Guideline for Prescribing Opioids for Pain, United States, 2022, MMWR Recommendations and Reports (CDC) (2022)
- Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl, Journal of Applied Laboratory Medicine (2024)
- Prolonged detection of urine norfentanyl in individuals enrolled in a medication for opioid use disorder in pregnancy and postpartum program: a case series, AJOG Global Reports (2024)
- An Opioid Hiding in Plain Sight: Loperamide-Induced False-Positive Fentanyl and Buprenorphine Immunoassay Results, Journal of Applied Laboratory Medicine (2022)
- LZI Fentanyl III Enzyme Immunoassay (510(k) K251634), U.S. Food and Drug Administration, 510(k) review document (2025)
- Labcorp Fentanyl Urine Visual Test (510(k) K252684), U.S. Food and Drug Administration, 510(k) review document (2026)
- Abnormal Urine Drug Screens in Pregnancy: Opportunity for Laboratory Stewardship, EJIFCC (2025)
- False-positive interferences of common urine drug screen immunoassays: a review, Journal of Analytical Toxicology (2014)
AI-verified against cited sources. Awaiting expert review. Last reviewed 2026-10-03. How we build and check these pages.